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Background: Interdisciplinary teamwork (ITW) is designed to promote the active participation of several disciplines
in delivering comprehensive cancer care to patients. ITW provides mechanisms to support continuous
communication among care providers, optimize professionals’ participation in clinical decision-making within and
across disciplines, and foster care coordination along the cancer trajectory. However, ITW mechanisms are not
activated optimally by all teams, resulting in a gap between desired outcomes of ITW and actual outcomes observed. The
aim of the present study is to identify the conditions underlying outcome production by ITW in local oncology teams.
Methods: This retrospective multiple case study will draw upon realist evaluation principles to explore associations
among context, mechanisms and outcomes (CMO). The cases are nine interdisciplinary cancer teams that participated
in a previous study evaluating ITW outcomes. Qualitative data sources will be used to construct a picture of CMO
associations in each case. For data collection, reflexive focus groups will be held to capture patients’ and professionals’
perspectives on ITW, using the guiding question, ‘What works, for whom, and under what circumstances?’ Intra-case
analysis will be used to trace associations between context, ITW mechanisms, and patient outcomes. Inter-case analysis will
be used to compare the different cases’ CMO associations for a better understanding of the phenomenon under study.
Discussion: This multiple case study will use realist evaluation principles to draw lessons about how certain contexts are
more or less likely to produce particular outcomes. The results will make it possible to target more specifically the actions
required to optimize structures and to activate the best mechanisms to meet the needs of cancer patients. This project
could also contribute significantly to the development of improved research methods for conducting realist evaluations of
complex healthcare interventions. To our knowledge, this study is the first to use CMO associations to improved empirical
and theoretical understanding of interdisciplinary teamwork in oncology, and its results could foster more effective
implementation in clinical practice.
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Given the nature of their illness and its multimodal
treatment, persons with cancer receive care from mul-
tiple professionals from different disciplines, working in
a variety of settings, whose services may be provided ei-
ther concurrently or at different points in time [1,2].* Correspondence: dominique.tremblay2@usherbrooke.ca
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unless otherwise stated.They are particularly susceptible to problems of fragmented
or poorly coordinated care, communication failures, and
breakdowns in care continuity, all of which compromise
their timely access to needed care [3]. This results in unmet
healthcare needs, with potentially harmful repercussions on
patients’ health and well-being [4,5]. To address these defi-
ciencies deplored by persons with cancer and their families,
clinicians, and decision-makers, several countries such as
Canada, the United Kingdom, the United States, and
Australia have made interdisciplinary teamwork (ITW) a
key element in their cancer care programs [6].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Quebec’s more than eight million residents enjoy a system
of universal access to healthcare. The Quebec Cancer Pro-
gram (PQLC – Programme québécois de lutte contre le
cancer), publicly launched in 1998, was intended particu-
larly to remedy deficiencies in service organization that had
negative impacts both on the response to patients’ and fam-
ilies’ needs and on the quality and efficiency of care [7].
Since then, strategic plans have given priority to service
reorganization, with a view to improving accessibility, con-
tinuity, person-centred care, and quality of care. This trans-
formation has been supported by measures to promote
better health services coordination and responsiveness.
These include the creation of interdisciplinary teams in on-
cology outpatient clinics, the deployment of pivot nurses
(also called nurse navigators in some parts of Canada), and
the adoption of a person-centred approach [8]. The princi-
pal investigator of the proposed study and several members
of the research team have conducted extensive research on
health services transformation [9-16].
The PQLC, as other international cancer programs, sup-
ports the implementation of a strategy that would com-
bine the efforts of all partners to produce the best possible
response to the needs of persons with cancer. The PQLC’s
2007 to 2012 policy priorities recommended focusing on
certain areas of intervention. ITW was presented as a so-
lution to address the complexity of care and services re-
quired to meet the needs of persons with cancer [17].
Numerous efforts have been made and significant re-
sources invested to encourage as many local oncology teams
as possible to respond to these expectations. However, as we
describe in greater detail below, the conclusions from evalu-
ations of oncology care and services have clearly shown that
ITW models vary from one team to another [3,8,18], as do
the expected impacts on the care experience [9].
Generally speaking, studies on ITW (also called team-
work, collaborative practice, interprofessional practice) have
concluded it produces benefits in terms of quality of patient
care [19-24]. A systematic review of the literature showed
that better interprofessional and interorganizational collab-
oration could be associated with positive outcomes, both
clinically (e.g., reduced mortality, shorter hospital stays,
fewer readmissions) and in terms of patients’ perceptions of
their care experience (e.g., greater satisfaction, improved
quality of life) [25]. However, in-depth critical analysis of
the evidence provides a more nuanced assessment of the
causal links between ITW and its effects on the care experi-
ence. The term ‘care experience’ refers to patients’ percep-
tions regarding key aspects of oncology care and services,
such as access to services, the quality of the response to
their needs, and the effectiveness of care when they interact
with service providers [26].
There are several reasons justifying the need for a
more thorough study of the conditions underlying theproduction of ITW outcomes as they relate to the care ex-
perience. First, the concept of interdisciplinary teamwork
goes by several different names (e.g., multidisciplinarity,
interdisciplinary teamwork, collaborative practice, inter-
professional collaboration), which are used interchangeably
but for which there are subtle differences of definition
[27,28]. Because the subject being examined is not clearly
defined and varies from one study to another, the result is
a non-homogeneous body of knowledge from which it
would seem rash to draw general conclusions on ITW out-
comes for patients. Second, most of the instruments used
in these studies to measure ITW focus on collaboration be-
tween physicians and nurses, whereas the outcomes may
be different for teams with a more diverse professional
composition [29], as is usually the case in oncology teams
in Quebec. Third, some conclusions regarding outcomes
related to ITW are also drawn from studies having to do
with cancer therapy review committees (‘tumour boards’)
[30,31], or else with interdisciplinary teams of specialist
physicians (oncologists, pathologists, internists, surgeons)
[32]. These teams focus on treatment options according to
the model of consultation among physicians in different
specialties rather than on comprehensive management of
the continuum of care based on a whole-person care prac-
tice model [33]. Consequently, the outcomes measured in
the participants in these studies have to do only with can-
cer treatments, rather than with the full experience of care
including treatments, as envisioned by the PQLC. Finally,
most of these studies provide very little information on the
characteristics of the teams and their operational models,
whereas ITW is known to be context-dependent [34]. One
common conclusion emerges from the literature review,
which is that, regardless of the type of interdisciplinary
team considered, the mechanisms by which ITW produces
specific outcomes in oncology, as they emerge in natural
settings, are currently receiving very little research atten-
tion and are poorly understood [25].
The proposed study will build upon a quasi-experimental
study recently conducted in nine Quebec hospitals with
1,379 patients (referred to as Study 1 in this proposal). The
results of that study revealed significant differences in cer-
tain ITW outcomes for patients according to the level of in-
terdisciplinarity (high vs. low) in local teams [9]. These
differences had to do with the time elapsed before accessing
a pivot nurse, the ability to contact the team when a need
arose, the possibility of being seen when there is a deterior-
ation in health status, the response to overall needs, assist-
ance and involvement with care decisions, and feelings of
anxiety and distress. Using multivariate regression analysis,
Study 1 also revealed that individual factors (e.g. male gen-
der, age 70 years and over, lower education level, positive
perception of one’s health status) and organizational factors
(e.g. receiving care from a team consisting of eight different
professionals or fewer, receiving care in a rural-area clinic)
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ence. These results confirm that certain teams in Quebec
manage to produce some of the desired outcomes of ITW,
while others are less successful. However, given its quasi-
experimental design [10], Study 1 was not able to capture
the factors and sequencing of processes that would explain
the variations in outcomes. Given the current lack of know-
ledge, the results of Study 1, and the efforts being made to
promote and support ITW in local oncology teams in Que-
bec, it is becoming imperative to better understand the
mechanisms by which outcomes are produced, by whom,
for what groups of patients, and in what contexts.
The aim of the present study is to map out the conditions
for the production of ITW outcomes in local oncology
clinics in Quebec. More specifically, the objectives are: a) to
identify the most critical contextual factors and mecha-
nisms associated with production of ITW patient out-
comes; b) to determine the synergetic or antagonistic
influences of contextual factors and mechanisms on the
production of ITW patient outcomes; and c) to explore the
occurrence of unanticipated ITW mechanisms and patient
outcomes.
ITW in oncology teams: intervention theory
Intervention theory refers to how the actors involved con-
ceive of ITW in oncology teams, its functioning and its out-
comes, as proposed by the PQLC. As part of the PQLC’s
implementation, all local oncology teams in Quebec are ex-
pected to become involved in optimizing their ITW
[11,12,17]. The aim is to ensure equity of access, without
undue delays, to good-quality and safe care all along the
cancer care continuum, from the first suspicion of illness to
the period of survival or family bereavement, encompassing
the entire period of active treatment and palliative care.
ITW is a means of responding to complex and changing
needs (of patients, families, and populations) by providing
customized care centred on the whole person, at the right
time, by the most appropriate professional, who is part of
an oncology team. ITW relies on ‘synergy among practi-
tioners (1 + 1 = 3)’ in a context of scarce resources, where
the contributions of all professionals need to be optimized
[13,17]. Additional file 1 contains more details for describ-
ing the intervention (ITW in oncology teams) in order to
improve the completeness of reporting and ultimately the
transferability of the study results.
ITW in clinical teams: patient outcomes
In addition to the outcomes targeted by the PQLC, there
are a number of other potential ITW outcomes identified
in the literature. Despite the previously mentioned con-
ceptual nuances characterizing the various terms applied
to ITW, for the purposes of the following literature review
we have adopted a pragmatic approach in which we con-
sider them to be similar.Overall, several studies have shown that ITW is associ-
ated with benefits for persons with chronic illnesses
[14-16,35]. The results cover a wide range of observed
outcomes, such as fewer clinical errors, complications,
and hospitalizations, and shorter lengths of stay [36-39].
Various studies also report positive impacts of ITW on pa-
tients’ and families’ satisfaction with services [40,41], main-
tenance of functional capacity [40,42-44], compliance with
treatment [44], greater accessibility to care, improved cap-
acity for self-care, and healthy living habits, [43], health-
promoting behaviours [43], and perceptions of better
quality of care [45]. According to Schmitt and colleagues
[43], ITW produces positive outcomes because it fosters a
whole-person approach to the management of care. Other
authors have associated positive outcomes with improved
mechanisms for communication among professionals,
who are increasingly working together toward a common
goal [46]. However, there is no evidence that these benefits
observed in other clienteles are transferable to patients
with cancer. We also did not find any negative patient out-
comes associated with ITW.
More specifically in oncology, a study in the United
Kingdom explored the care experience of adolescents with
cancer who were treated by an interdisciplinary team [47].
One conclusion of that qualitative study was that ITW in
dedicated and specialized teams is a key element in creat-
ing a care environment that is responsive to the complex
needs of this clientele. More recently, a study in a hospital
in Spain showed that a higher level of ITW in the oncol-
ogy care units was significantly associated with better pain
management, higher levels of satisfaction among patients,
and reduced uncertainty related to their illness [35]. That
same study concluded that the intensity of collaboration
had no impact on length of hospital stay. Our own work
in Study 1 showed that ITW outcomes varied from one
team to another. In some teams, the results confirmed our
initial hypothesis of positive covariance between ITW level
and the scope of effects for patients, i.e., that higher ITW
levels would be accompanied by more positive patient per-
ceptions of its effects on their experience. However, we
found that, for certain aspects of the care experience,
teams with lower ITW levels obtained results that were
just as positive as those with higher ITW levels. Our re-
sults also showed that teams with a high level of ITW
achieved outcomes that were less substantial than ex-
pected. While it is not clear why or how, it appears there
may be one or more intermediate factors acting as moder-
ator or mediator in the relationship between ITW and pa-
tient outcomes.
We should also point out that our results align with the
conclusions of other authors regarding the need for further
studies to better understand the links between ITW and its
effects on quality of care. A recent review of the literature
on ITW in oncology [33] reached the same conclusion as
Tremblay et al. Implementation Science 2014, 9:76 Page 4 of 11
http://www.implementationscience.com/content/9/1/76Lemieux-Charles and colleagues in 2006 [23], which was
that studies establishing links between quality of team func-
tioning and clinical effectiveness are few and far between,
and offer inconsistent results. Some authors have criticized
scientific journals’ tendency to publish only studies showing
positive results of ITW [34], which constitutes a publication
bias; they note the real absence of studies that observed ei-
ther no effects or negative effects of ITW. According to
these authors, this bias has meant that ITW is becoming a
standard that is less and less subject to critical analysis.
They also point out that many literature reviews on ITW in
care teams have concluded that outcomes are positive with-
out having evaluated the quality of the studies. Assessing
the quality of the studies might reveal that the outcomes
are less robust than is generally thought. There is also evi-
dence that intra- and interprofessional collaborative prac-
tice is a best practice associated with credible patient
outcomes [24]. Thus, given its nature and its effects, ITW
can be approached as a complex intervention. According to
the Medical Research Council, a complex intervention is
characterized by several interdependent components, in-
volves the practices of several actors in the healthcare sys-
tem, and produces a variety of effects whose nature and
scope can vary depending on the context [48]. Several au-
thors agree that exploring these interventions more deeply
presents very particular conceptual and methodological
challenges [49-51].
ITW in oncology teams: the challenges of evaluating
complex interventions
The ‘realistic evaluation’ approach developed by Pawson
and Tilley [52] is recognized as being useful for studying
complex interventions when the aim is to go beyond deter-
mining whether an intervention is effective or not, and in-
stead to explain how and why it is effective, under what
conditions, and for which groups of patients. To be a ‘real-
istic evaluation’, the approach must be able to capture the
contextualized action mechanisms at work in the relation-
ship between an intervention and its effects, and to identify
how these mechanisms are activated (or not). A mechan-
ism refers to all ‘underlying entities, processes, or struc-
tures which operate in particular contexts to generate
outcomes of interest’ [53]. Realistic evaluation is based on
the theory: intervention context (C) +mechanism (M) =
outcome (O), analyzed using a configurational approach.
CMO configurations serve as a structure to identify what
works (or not), how, by whom, with whom, for whom, and
in what context. This theory is appropriate to guide our
study because it links the conditions of production (C +M)
and the outcomes (O) of an intervention according to a
structured evaluation approach to what is actually happen-
ing in natural environments. It offers the possibility of
deepening our understanding of ITW outcomes in oncol-
ogy by identifying the synergetic or antagonistic effects inthese associations among various contextual factors and
action mechanisms that either foster or hinder the pro-
duction of outcomes (Objectives 1 and 2 of the present
study). The realistic evaluation approach is a pragmatic
alternative to the experimental paradigm, given the impos-
sibility of controlling complex interventions in natural en-
vironments, such as ITW [54]. Realistic evaluation thus
offers a systematic investigative structure with two key ad-
vantages: it can take into account a multiplicity of vari-
ables and their relationships implied in the production of
an intervention’s outcomes; and it can be used, at the same
time, to minimize this complexity by modelling the rela-
tionships based on configurations of the three main di-
mensions: context–mechanisms–outcomes; both of these
advantages facilitate the investigation and support poten-
tial action by users of the study’s results. Thus, contextual
factors are considered not as variables to be controlled, as
would be the case in experimental studies, but rather as
intrinsic components of the phenomenon under study.
In addition to these theoretical foundations, realistic
evaluation provides five key principles to consider in the re-
search process: a) stakeholder participation in a study is re-
quired to understand – realistically – CMO configurations;
b) mechanisms are theories developed based on proposi-
tions that ‘if things work this way in a given context, these
will be the results’; c) CMO configurations may be estab-
lished at the start, but they will be refined throughout the
course of the study; d) causal links are generated as the
study unfolds by determining how the variables are associ-
ated, rather than simply by measuring the correlation be-
tween a variable and a given outcome (as was done in
Study 1); and e) the expected outcomes of an intervention
are never guaranteed because of the central role played by
the context [54,55]. These realistic evaluation principles
suggest that the first thing to do is to target the mecha-
nisms that are likely to be active in the phenomenon before
starting the study. In the following sections, realistic evalu-
ation concepts are used to identify the contextual factors
and mechanisms that are potentially involved in the pro-
duction of ITW outcomes.
ITW in oncology teams: contextual factors
Those researchers who have a critical approach to ITW
agree on the importance of context in explaining its varia-
tions. Context refers to the immediate and more distant en-
vironments whose structural characteristics shape care
delivery [56]. As such, it is important to analyze context dy-
namically. Several contextual factors can contribute to the
effectiveness of teams’ functioning [23,57,58]. These factors
fall into three groups defined according to decision-making
levels in the health system. The first group is at the practice
(micro) level and encompasses the characteristics of profes-
sionals (e.g., profession, training, experience, leadership), pa-
tients’ clinical and sociodemographic characteristics (e.g.,
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comorbidities), and team characteristics (e.g., composition,
size, nature of mandate, work climate) [59-61]. The second
group is at the organizational (meso) level and includes in-
stitutional support, access to resources, leadership, etc. [15].
The third group is at the systemic (macro) level and com-
prises policies, national programs, legislative frameworks
governing professional practice, etc. [62]. Each of these fac-
tors can exert variable influence in different CMO configu-
rations, influences that will be more clearly delineated by
the results of this present study.
ITW in oncology teams: mechanisms associated with
outcomes production
Based on the ITW attributes described in the intervention
theory coming out of the PQLC documents, it is possible
to identify certain mechanisms that are potentially associ-
ated with the production of ITW outcomes in oncology.
The first attribute – the bringing together of several prac-
titioners – presents the challenge of sharing in the group
the expertise, knowledge, and experience of professionals
from different disciplines, who each have their own spe-
cific skills [34]. For a group of heterogeneous practitioners
to rally around a common goal and collaborate, an effective
communication mechanism must be in place and active
[25,57,63-66]. The second attribute – working together –
requires a mechanism for care coordination to ensure con-
tinuity of care [25,66]. When coordination is active, team
members function interdependently, with each person’s
contribution being important to optimize the management
of information, clinical processes, and resources [67]. The
third attribute – a global, shared, and unified understanding
of the person – introduces the mechanism of patient-
centred care [68]. Thus, instead of fragmented services
centred around issues of professionalization, patients are
presented with a person-centred care model in which an
interdisciplinary care plan can be developed with objectives
shared by the different practitioners on the team [69]. The
fourth attribute –a concerted intervention that involves the
sharing of complementary tasks – can refer both to a col-
laboration mechanism within the team and to integration
between organizations [28,70]. Finally, a fifth attribute ap-
pears to be essential for optimizing outcomes – evidence-
based practice supported by a scientific knowledge utilization
mechanism. Given the multidimensional nature of each of
these mechanisms, it is worthwhile to characterize them
here more clearly and to identify their potential effects based
on the literature (see Additional file 2 for a detailed descrip-
tion and references).
ITW in oncology teams: interpretive framework
The intervention (ITW) coming out of the PQLC docu-
ments, the literature on ITW (definition, facilitating fac-
tors, constraining factors, outcomes), and the dimensionsof realistic evaluation brings us to develop an interpretive
framework (Figure 1).
The framework thus incorporates three broad compo-
nents surrounding ITW: a) the context, including charac-
teristics of the environment, characteristics of the oncology
clientele that could have an influence on the organization
of the continuum of care and services, and characteristics
of the organization and the team; b) mechanisms put for-
ward to achieve ITW outcomes (communication, coordin-
ation, collaboration, person-centred care, negotiations and
mutual adjustments, scientific knowledge utilization, and
others that may be unforeseen); and c) the expected out-
comes of ITW based on the intervention theory set out in
the PQLC and the policy priorities as promised by the Que-
bec’s Department of Cancer Services. Using the data from
Study 1, we will analyze the contextual factors and the
mechanisms (C +M) associated with certain outcomes of
interdisciplinarity that are comprised of several dimensions.
We will analyze: responsiveness [71], which can be
broken down into four subdimensions (promptness of
access to care in response to patients’ needs, and the
quality of communication, of the care environment, and
of the person-centred response); continuity of care [72];
care outcomes [73] (management of symptoms and of
health), as well as two subscales of the questionnaire on
the capacity for self-care [74] (well-being and navigation
of the healthcare system).
In light of these points, the key theories to be explored
initially are:
1. Initial theory: that there is a positive relationship
between ITW and certain aspects of the care
experience as perceived by patients.
2. Alternative theory A: that there is a synergy (1 + 1 = 3)
between certain contextual factors and certain
mechanisms of team functioning that have a
mediating influence on the relationship between ITW
in oncology and patients’ perception of certain aspects
of their care experience.
3. Alternative theory B: that there is an antagonistic
association (1 + 1 = 1) between certain contextual
factors and certain mechanisms of team functioning
that have a moderating influence on the relationship
between ITW in oncology and patients’ perception
of certain aspects of their care experience.
Methods
Design
The study will use a retrospective multiple case study
(n = 9) design [75]. Case study is an appropriate ap-
proach for characterizing clinical and organizational
processes in their contexts [75-77]. This is, in fact, the
study design most often used by researchers investigat-
ing CMO configurations in the healthcare field [78-81].
Figure 1 Interpretive framework for evaluating the conditions for the production of ITW outcomes in oncology. 1) Programme québécoise de
lutte contre le cancer (Quebec Cancer Program).
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ogy working in the ambulatory clinic of a hospital. We
will perform intra-case analyses to identify the CMO
configurations, and then a cross-cutting inter-case ana-
lysis [82] to compare the cases. The study is retrospect-
ive, in that we will proceed in reverse to reconstruct the
C +M associations that explain the outcomes measured
in Study 1 (responsiveness, continuity, care outcomes,
capacity for self-care) [83].Case selection
The nine sites that participated in Study 1 will be in-
vited to participate in the present study. For a multiple
case study, the aim is not to have a sample that is statis-
tically representative of a population, but rather to have
the most informative cases possible, in which the fea-
tures observed are likely to exist in other cases of popu-
lations with similar characteristics [76,82,84]. The
diversity of the cases studied will allow us to observe
recursive or singular CMO configuration models and
to draw conclusions that could potentially be transfer-
able to the different teams across Quebec.Participants
The data, which will be qualitative, will be collected primar-
ily by means of focus groups [85]. For each site, two differ-
ent participant groups will be formed: G1 will be made up
of the professionals in the oncology care team and the
managers directly involved in the team’s deployment of
ITW; G2 will consist of patients who have received services
from that team. The number of participants per group will
be around 6 to 10, perhaps going as high as 15 in certain
cases, depending on the size of the local oncology team
[86]. The criterion for inclusion in G1 is membership on
the team for at least the past three years, to be able to pro-
vide an evolutionary perspective of the context and mecha-
nisms put forward to support ITW since the start of Study
1. The criteria for inclusion in G2 (patients) are: a) to be
comfortable with participating in a group discussion, and b)
to have been in active treatment during the past year, such
that they have had enough ‘exposure’ to the interdisciplin-
ary team to be able to draw some conclusions about their
care experience. They will be purposefully selected, with
the help of a member of the local team, to ensure a diver-
sity of sociodemographic characteristics (sex, age, educa-
tion) and of clinical characteristics (type of treatment, type
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was a strategic choice. It allows for spontaneous but fo-
cused discussion to better understand the conditions for
the production of ITW outcomes from the perspectives of
the persons most directly concerned. Focus groups provoke
a ‘good conversation’ on the phenomenon being studied
and make the best use of the limited time available to the
group for in-depth consideration of the subject [88]. Par-
ticular attention will be paid to five criteria for assessing the
success of a focus group: a) the intended topics are covered,
and in sufficient depth; b) the statements elicited provide
rich, diverse and nuanced testimony; c) participation is ac-
tive, spontaneous and balanced; d) there is interaction and
mutual influence, but no excessive dominance by any
participants; and e) the group process contributes to re-
flection that allows participants to embark in a change
process [85]. In this way, we will be able to cover all of
the potential explanatory factors for the production of
ITW outcomes by starting from the outcomes and
working backwards to investigate the conditions (con-
text and mechanisms) that determine them [83] (Objec-
tives 1 and 2), while the spontaneity and dynamic
nature of the group will enrich the explanations and
help to identify unanticipated mechanisms and out-
comes (Objective 3).
The focus group data will be triangulated with com-
plementary data gleaned from the relevant documenta-
tion (meeting minutes, medical records charting tools,
inter-professional and inter-organizational referral tools)
and from informal discussions [82].
Data collection
Data will be systematically collected in the focus groups
with professionals and patients by means of pre-defined
questions presented in the focus group meeting plan (see
Additional file 3). The groups will be facilitated by the co-
investigators, who have extensive experience in oncology
and in leading oncology team meetings. The professionals
will be invited to reflect on the conditions that might ex-
plain the ITW outcomes in their setting. These outcomes,
measured in Study 1, are presented in the local reports
distributed to the teams in 2012. Those reports summarize
the context of Study 1 and its methodology, and present
descriptive statistics from the responses to the question-
naire on accessibility, responsiveness, continuity, capacity
for self-care, and characteristics of respondents. The re-
port presenting both local and global results (aggregated
for the nine sites) will be used as an intermediary object
[89] in a reflexive process (learning about and in practice)
[90] and as a means of encouraging discussion. For items
that characterize the greatest variation in the care experi-
ence of patients receiving care from the local team, the
professionals will take a position on what they think about
the results, as well as on the gaps between local and globalresults and how they might be explained: what mechanisms
facilitate the production of ITW outcomes; what mecha-
nisms contribute to maintaining practices that are less
interdisciplinary; and by whom, with whom, and for whom
outcomes are produced, and in what specific contexts.
With regard to the patient focus groups, the local report
is considered too abstract to provoke any discussion on
the care experience. As such, the intermediary object
chosen for that purpose will be a vignette covering the ac-
tive treatment period. Used in research, a vignette is a brief
scenario presented either in writing or through picto-
grams, which serves as a proxy for a real situation, and to
which participants are invited to respond [91]. The vi-
gnette has several advantages: it helps depersonalize the
discussion while keeping the focus on the phenomenon
under study, and it is a standardized, flexible, and inexpen-
sive tool. As we did in an earlier study to assess the quality
of care in oncology [92], we will reconstruct the cancer
care continuum of a patient with colon cancer (post-sur-
gery diagnosis, first phase of chemotherapy, progression of
the illness, and decision to pursue more aggressive treat-
ment), inserting certain items that showed the greatest
variation in ITW outcomes when measured in Study 1.
For example, the vignette will address items related to re-
sponsiveness by illustrating such things as participation in
decisions about care, help in weighing the pros and cons
of treatment, family involvement, and support in man-
aging anxiety when dealing with illness.
The questions used to structure the discussion are in-
spired by realistic evaluation and are aimed not only at
identifying ITW outcomes (the ‘what’), but also at explain-
ing how and why those outcomes are produced. At each
focus group meeting, we will explain the process we in-
tend to follow, then present a summary of the results of
Study 1, followed by a discussion as presented in the focus
group outline provided in the Additional file 3 [93]. The
discussions will be digitally recorded and then transcribed
in their entirety for analysis. All the material will be en-
tered into a database using QDA Miner software [94].
Data analysis
The data will be analyzed using an iterative content ana-
lysis process with systematic coding [95,96]. The analysis
will be structured based on the 10 steps developed by Ely
[97]. First, we will develop a semi-structured coding grid
based on the concepts of our interpretive framework (con-
text, mechanisms, outcomes) leaving open the possibility
of adding emerging concepts to the CMO configurations
over the course of the analysis [98]. The data for each case
will be analyzed separately. Then we will perform an inter-
case analysis to identify similar and different CMO config-
urations in the different cases. According to Campbell
[99], certain case characteristics may only become evident
through inter-case comparisons. Finally, we will use a
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analyses to ensure that we are able to satisfy the objectives
of the study and to produce enough evidence to facilitate
the transferability of our results to other organizations
whose characteristics are similar to those in our study cases.
To ensure the quality of the analysis, the members of the re-
search team will discuss the coding process and results
among themselves and also with collaborators and key
stakeholders (members of professional teams, managers,
decision-makers) in validation meetings. If we are able to
identify patients who would be at ease and willing to partici-
pate in such validation discussions, they will be included.
The study has been approved by the Research Ethics
Board of the Charles-LeMoyne Hospital Research Centre
(ref. number MP-HCLM-13-034).
Study validity
In this study, we will pay special attention to ensuring
both internal and external validity. Internal validity refers
to the degree of similarity and plausibility that exists be-
tween the knowledge construction process, the complexity
of a phenomenon in its natural setting, and the results of a
study [95]. We have employed several means to ensure the
internal validity of our study: using cases whose character-
istics we know well from having worked with them in
Study 1 [75,83]; incorporating an extensive review of the
ITW literature; building on the theoretical foundations
and methodologies of realistic evaluation [100]; and tri-
angulating several data sources [101], i.e., the perspectives
of professionals and patients, as well as documentary ana-
lysis. We will triangulate data sources using two strategies
that highlight different aspects of the conditions for pro-
duction of ITW outcomes: a) the comparison of similar-
ities and differences in the perspectives of the various
actors with regard to the context (C) and mechanisms (M)
of interdisciplinary care and the C +M links in the pro-
posed study; and b) the validation of data from the inter-
views as compared with the data from documentary
sources [87]. In our proposed study, the solidity of the
links established between context, mechanisms and out-
comes is reinforced by the study of multiple cases [82]
and by the complementarity of the quantitative and quali-
tative research approaches of Study 1 and the present
study [102,103]. Moreover, Rohlfing (2008) asserts that, by
taking outcomes as the starting point and working back-
ward to investigate the conditions that determine them,
we are more likely to capture the whole range of causes
that might have influenced the outcomes [83]. With re-
gard to external validity, it has to do with the degree to
which a study’s results can be generalized to other popula-
tions, settings, and time periods having similar characteris-
tics [104]. However, case study, in the context of realistic
evaluation, does not aim for quantitative or statistical
generalizability, but rather to provide plausible explanationsobtained from a sample in which, ‘if things work this way,
these will be the results.’ These explanations can be general-
ized to other contexts where the organizational and environ-
mental conditions are similar [95].
Discussion
To the best of our knowledge, this study is the first to use
CMO associations to improved empirical and theoretical
understanding of interdisciplinary teamwork in oncology,
and its results could foster more effective implementation
in clinical practice. This study will have significant impacts
because the results will foster innovation by helping to fill
the gaps in knowledge about the strongly contextualized
mechanisms responsible for differences in ITW outcomes
in oncology. It will be possible to identify which are the
most critical mechanisms to activate, to determine whether
certain mechanisms are more important than others, and
to specify in which contexts these mechanisms are most
active. With a better understanding of these factors, it will
be possible to target interventions to act on the determin-
ing conditions in ways that optimize positive outcomes.
Settings with less favourable conditions can be better sup-
ported in their efforts to optimize ITW. Given the study
design, the results will be useful for different types of actors
at different levels of the healthcare system, i.e., clinicians,
managers, and decision-makers who determine strategic
actions in the PQLC’s policy priorities. These new data will
be especially important in a context where every profes-
sional’s contribution will need to be optimized, to contend
with the rising incidence of cancer as the population ages
and the limited resources of the healthcare system.
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(professionals and patients).
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